These findings suggest that a single TA-CIN vaccination, with priming using pNGVL4a-CRT-E6E7L2 DNA, may elicit L2-specific cross-neutralizing antibodies that could reduce the potential for re-infection or spread in an infected host. This evidence concerns the gene PDXP and infection.